Autopsy report · NCT03716778
Rehabilitation by Eccentric Exercise in Heart Failure Patients
Cause of deathStaffing, sites or logistics
“This premature end of the study is due to the lack of human resources and the fact that the forceps used to perform the biopsies for this study have not been marketed since January 2023.”
Life of this trial
- Registered 1 month before it started.
- Ran for about 3 years 7 months before it stopped.
- 23 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- University Hospital, Clermont-Ferrand
- Sponsor type
- University, hospital or other
- Conditions
- Chronic Heart Failure Patient; Rehabilitation Program
- Interventions
- Eccentric rehabilitation sessions
- Participants
- 23
- Sites
- 1
- Countries
- France
Trials that died the same way
- EBUS-TBNA Versus EBUS-TBNB
“Manufacturer did not develop and deliver the necessary biopsy forceps needles in time” - Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma
“The lack of adequate funding has made it impossible to continue with the clinical study As this study was not initiated, no subject was included and no data was collected,thus no result can be obtained SPONSOR\_DECISION End of trial date:15 Oct 2025” - Thrombosomes® in Bleeding Thrombocytopenic Patients Study
“This study was terminated due to loss of funding for this indication from the Biomedical Advanced Research and Development Authority (BARDA) in November 2022.” - Phase II Biomarker Study Comparing the Combination of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus the Combination After Monotherapy With Dabrafenib or Trametinib
“The study was terminated early due to slow enrollment and limited numbers of viable tissue samples.” - Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer
“The study was terminated due to futility and lack of future funding”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.